Document Detail


The Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study: paving the way for new diagnostic criteria for gestational diabetes mellitus.
MedLine Citation:
PMID:  20510967     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study was performed in response to the need for internationally agreed upon diagnostic criteria for gestational diabetes, based upon their predictive value for adverse pregnancy outcome. Increases in each of the 3 values on the 75-g, 2-hour oral glucose tolerance test are associated with graded increases in the likelihood of pregnancy outcomes such as large for gestational age, cesarean section, fetal insulin levels, and neonatal fat content. Based upon an iterative process of decision making, a task force of the International Association of Diabetes and Pregnancy Study Groups recommends that the diagnosis of gestational diabetes be made when any of the following 3 75-g, 2-hour oral glucose tolerance test thresholds are met or exceeded: fasting 92 mg/dL, 1-hour 180 mg/dL, or 2 hours 153 mg/dL. Various authoritative bodies around the world are expected to deliberate the adoption of these criteria.
Authors:
Donald R Coustan; Lynn P Lowe; Boyd E Metzger; Alan R Dyer;
Related Documents :
6988747 - Plasma insulin and glucagon responses to isoglycemic stimulation in normal pregnancy an...
23211927 - Adiposity in adolescent offspring born prematurely to mothers with preeclampsia.
1671017 - Fructosamine as a screening-test for gestational diabetes mellitus: a reappraisal.
7956437 - Massive hemoptysis in takayasu's arteritis during pregnancy.
22759847 - Sexual practice associated with knowledge in adolescents in ninth grade.
17710247 - Perinatal changes of cardiac troponin-i in normal and intrauterine growth-restricted pr...
Publication Detail:
Type:  Journal Article; Practice Guideline; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  American journal of obstetrics and gynecology     Volume:  202     ISSN:  1097-6868     ISO Abbreviation:  Am. J. Obstet. Gynecol.     Publication Date:  2010 Jun 
Date Detail:
Created Date:  2010-05-31     Completed Date:  2010-06-22     Revised Date:  2011-07-28    
Medline Journal Info:
Nlm Unique ID:  0370476     Medline TA:  Am J Obstet Gynecol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  654.e1-6     Citation Subset:  AIM; IM    
Copyright Information:
Copyright 2010 Mosby, Inc. All rights reserved.
Affiliation:
Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Warren Alpert Medical School of Brown University, Women & Infants Hospital of Rhode Island, Providence, RI, USA. dcoustan@wihri.org
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Blood Glucose / analysis*
Diabetes, Gestational / diagnosis*,  drug therapy
Female
Glucose Tolerance Test
Humans
Insulin / therapeutic use
Odds Ratio
Predictive Value of Tests
Pregnancy
Pregnancy Outcome
Grant Support
ID/Acronym/Agency:
M01-RR00048/RR/NCRR NIH HHS; M01-RR00080/RR/NCRR NIH HHS; R01 HD034242-01A2/HD/NICHD NIH HHS; R01 HD034243-01A2/HD/NICHD NIH HHS; R01 HD034243-02/HD/NICHD NIH HHS; R01 HD034243-03/HD/NICHD NIH HHS; R01 HD034243-04/HD/NICHD NIH HHS; R01 HD034243-05/HD/NICHD NIH HHS; R01 HD034243-06/HD/NICHD NIH HHS; R01 HD034243-07/HD/NICHD NIH HHS; R01 HD034243-08/HD/NICHD NIH HHS; R01 HD034243-09/HD/NICHD NIH HHS; R01-HD34242/HD/NICHD NIH HHS; R01-HD34243/HD/NICHD NIH HHS
Chemical
Reg. No./Substance:
0/Blood Glucose; 11061-68-0/Insulin
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Is there a benefit to the treatment of mild gestational diabetes mellitus?
Next Document:  Current status of the subspecialty of female pelvic medicine and reconstructive surgery.